Kawasaki Disease (Mucocutaneous Lymph Node Syndrome)
Differential diagnosis of Kawasaki disease | Download Table
Kawasaki Disease Substantially Impacts Health-Related Quality of Life - The Journal of Pediatrics
Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial - The Lancet
Antithrombotic therapy in KD based on CAA size - UpToDate
What is Kawasaki Disease? | www.kawasakidiseaseindia.org
Minerva Pediatrica Insights on Kawasaki disease and multisystem inflammatory syndrome; Relationship with COVID-19 infection
Flowchart of enrollment and classification of the subjects. KD:... | Download Scientific Diagram
Kawasaki syndrome - The Lancet
Diagnosis and Management of Kawasaki Disease - American Family Physician
Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease | Italian Journal of Pediatrics | Full Text
Diagnosis and Management of Kawasaki Disease - American Family Physician
Classification and etiology of 120 cases of innominate artery aneurysms. | Download Table
Frontiers | How Should We Classify Kawasaki Disease? | Immunology
Z- score classification of coronary aneurysms in Kawasaki disease
Kawasaki Disease | SpringerLink
Flow of ascertainment of the 467 cases with Kawasaki disease (KD) and... | Download Scientific Diagram
Table 1 from Improved Classification of Coronary Artery Abnormalities Based Only on Coronary Artery z-Scores After Kawasaki Disease | Semantic Scholar
Kawasaki Disease
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association | Circulation
Frontiers | Risk Factors of Coronary Artery Abnormality in Children With Kawasaki Disease: A Systematic Review and Meta-Analysis | Pediatrics
Kawasaki disease in 2019—past controversies, present insights and future directions - Grignani - Pediatric Medicine
SciELO - Brasil - Doença de Kawasaki Doença de Kawasaki
Proteomic analysis associated with coronary artery dilatation caused by Kawasaki disease using serum exosomes | Revista Portuguesa de Cardiologia
National consensus on the cardiological treatment and follow-up of Kawasaki disease | Anales de Pediatría
Kawasaki disease. KD was initially described in the medical literature by Tomisaku Kawasaki in At that time, there were 50 cases that had been followed. - ppt download
National consensus on the cardiological treatment and follow-up of Kawasaki disease | Anales de Pediatría
